204 related articles for article (PubMed ID: 22706526)
1. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
[TBL] [Abstract][Full Text] [Related]
3. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.
Komohara Y; Ma C; Yano H; Pan C; Horlad H; Saito Y; Ohnishi K; Fujiwara Y; Okuno Y; Nosaka K; Shimosaki S; Morishita K; Matsuoka M; Wakayama T; Takeya M
J Clin Exp Hematop; 2017 Jul; 57(1):15-20. PubMed ID: 28420814
[TBL] [Abstract][Full Text] [Related]
4. Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.
Kobayashi S; Watanabe E; Ishigaki T; Ohno N; Yuji K; Nakano K; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2015 May; 106(5):598-603. PubMed ID: 25703103
[TBL] [Abstract][Full Text] [Related]
5. CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
Manivannan K; Rowan AG; Tanaka Y; Taylor GP; Bangham CR
PLoS Pathog; 2016 Apr; 12(4):e1005560. PubMed ID: 27105228
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.
Nakahata S; Syahrul C; Nakatake A; Sakamoto K; Yoshihama M; Nishikata I; Ukai Y; Matsuura T; Kameda T; Shide K; Kubuki Y; Hidaka T; Kitanaka A; Ito A; Takemoto S; Nakano N; Saito M; Iwanaga M; Sagara Y; Mochida K; Amano M; Maeda K; Sueoka E; Okayama A; Utsunomiya A; Shimoda K; Watanabe T; Morishita K
Haematologica; 2021 Feb; 106(2):532-542. PubMed ID: 32054656
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia.
Sasaki H; Nishikata I; Shiraga T; Akamatsu E; Fukami T; Hidaka T; Kubuki Y; Okayama A; Hamada K; Okabe H; Murakami Y; Tsubouchi H; Morishita K
Blood; 2005 Feb; 105(3):1204-13. PubMed ID: 15471956
[TBL] [Abstract][Full Text] [Related]
8. Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB.
Sarkar B; Nishikata I; Nakahata S; Ichikawa T; Shiraga T; Saha HR; Fujii M; Tanaka Y; Shimoda K; Morishita K
Sci Rep; 2019 Mar; 9(1):3491. PubMed ID: 30837480
[TBL] [Abstract][Full Text] [Related]
9. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.
Kobayashi S; Nakano K; Watanabe E; Ishigaki T; Ohno N; Yuji K; Oyaizu N; Asanuma S; Yamagishi M; Yamochi T; Watanabe N; Tojo A; Watanabe T; Uchimaru K
Clin Cancer Res; 2014 Jun; 20(11):2851-61. PubMed ID: 24727323
[TBL] [Abstract][Full Text] [Related]
10. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma.
Chilmi S; Nakahata S; Fauzi YR; Ichikawa T; Tani C; Suwanruengsri M; Yamaguchi R; Matsuura T; Kurosawa G; Morishita K
Int J Hematol; 2020 Oct; 112(4):496-503. PubMed ID: 32656636
[TBL] [Abstract][Full Text] [Related]
12. Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
[TBL] [Abstract][Full Text] [Related]
13. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
14. CD4
Makiyama J; Kobayashi S; Watanabe E; Ishigaki T; Kawamata T; Nakashima M; Yamagishi M; Nakano K; Tojo A; Watanabe T; Uchimaru K
Cancer Sci; 2019 Dec; 110(12):3746-3753. PubMed ID: 31642546
[TBL] [Abstract][Full Text] [Related]
15. CADM1/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases.
You Y; Zhang J; Li Y; Li Y; Shi G; Ma L; Wei H
Mol Med Rep; 2014 Nov; 10(5):2621-6. PubMed ID: 25215547
[TBL] [Abstract][Full Text] [Related]
16. CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.
Masuda M; Maruyama T; Ohta T; Ito A; Hayashi T; Tsukasaki K; Kamihira S; Yamaoka S; Hoshino H; Yoshida T; Watanabe T; Stanbridge EJ; Murakami Y
J Biol Chem; 2010 May; 285(20):15511-15522. PubMed ID: 20215110
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
18. HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K; Hashikura Y; Takaki A; Kimura M; Kawano K; Iwao C; Miyauchi S; Kawaguchi T; Matsuda M; Hashiba Y; Hidaka T
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851682
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
Pujari R; Hunte R; Thomas R; van der Weyden L; Rauch D; Ratner L; Nyborg JK; Ramos JC; Takai Y; Shembade N
PLoS Pathog; 2015 Mar; 11(3):e1004721. PubMed ID: 25774694
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
